What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2020?

133 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 40,230,477
Share change: +922,222
Total reported value: $290,007,852
Put/Call ratio: 24%
Price per share: $7.21
Number of holders: 133
Value change: +$8,150,488
Number of buys: 61
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ArrowMark Colorado Holdings LLC	13F	Company	7.8%	8,824,526	$41,299,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	4.2%	4,747,693	$22,218,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	3.2%	3,641,950	$17,044,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	3%	3,364,140	$15,744,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	1.9%	2,177,654	$10,191,000	—	31 Mar 2020	13F
Park West Asset Management LLC	13F	Company	1.4%	1,597,507	$7,476,000	—	31 Mar 2020	13F
Fiera Capital Corp	13F	Company	1.1%	1,190,511	$5,572,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.85%	966,914	$4,525,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.71%	800,582	$3,746,000	—	31 Mar 2020	13F
Sio Capital Management, LLC	13F	Company	0.66%	752,241	$3,520,000	—	31 Mar 2020	13F
AVIVA PLC	13F	Company	0.53%	594,701	$2,783,000	—	31 Mar 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.52%	590,000	$2,761,000	—	31 Mar 2020	13F
DAFNA Capital Management LLC	13F	Company	0.4%	450,900	$2,110,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.38%	425,000	$1,989,000	—	31 Mar 2020	13F
BAILARD, INC.	13F	Company	0.36%	407,200	$1,906,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.35%	390,607	$1,828,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.32%	366,580	$1,716,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	330,100	$1,545,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.28%	315,162	$1,475,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.27%	301,597	$1,411,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.26%	299,795	$1,403,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.25%	280,956	$1,314,000	—	31 Mar 2020	13F
WINTON GROUP Ltd	13F	Company	0.24%	267,926	$1,254,000	—	31 Mar 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.23%	259,058	$1,212,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.22%	254,426	$1,191,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.22%	249,137	$1,166,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.2%	226,905	$1,062,000	—	31 Mar 2020	13F
David M. Knott	13F	Individual	0.19%	218,102	$1,021,000	—	31 Mar 2020	13F
Rhenman & Partners Asset Management AB	13F	Company	0.18%	200,000	$936,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.16%	175,927	$823,000	—	31 Mar 2020	13F
SG Americas Securities, LLC	13F	Company	0.15%	173,732	$813,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	168,512	$788,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.15%	168,153	$787,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.13%	150,486	$704,000	—	31 Mar 2020	13F
Employees Retirement System of Texas	13F	Company	0.12%	138,826	$650,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	132,300	$619,000	—	31 Mar 2020	13F
ALPS ADVISORS INC	13F	Company	0.12%	131,378	$615,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.12%	130,349	$610,000	—	31 Mar 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.11%	129,714	$607,000	—	31 Mar 2020	13F
Ikarian Capital, LLC	13F	Company	0.11%	126,159	$590,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.11%	125,219	$585,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.11%	124,400	$582,000	—	31 Mar 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.11%	128,053	$575,000	—	31 Mar 2020	13F
Cornerstone Capital, Inc.	13F	Company	0.1%	111,775	$523,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	109,358	$512,000	—	31 Mar 2020	13F
L & S Advisors Inc	13F	Company	0.1%	107,931	$505,000	—	31 Mar 2020	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.09%	105,700	$495,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	99,687	$467,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.08%	87,125	$408,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.08%	86,663	$405,583	—	31 Mar 2020	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2020

As of 30 Jun 2020, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,230,477 shares. The largest 10 holders included ArrowMark Colorado Holdings LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, FMR LLC, Park West Asset Management LLC, NORTHERN TRUST CORP, FIERA CAPITAL CORP, GEODE CAPITAL MANAGEMENT, LLC, and Sio Capital Management, LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

130

Q2 2020 holders

133

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.